<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1151557</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The traditional Chinese medicine and non-small cell lung cancer: from a gut microbiome perspective</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xuelin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2164439"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hou</surname>
<given-names>Liming</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cui</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Junnan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Mengzhou</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xie</surname>
<given-names>Jianwu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2165856"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Food Science and Engineering (School of Biological and Pharmaceutical Sciences), Shaanxi University of Science &amp; Technology</institution>, <addr-line>Xi an</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Geriatrics, Xijing Hospital, Fourth Military Medical University</institution>, <addr-line>Xi an</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Tianhao Liu, Affiliated Hospital of Jiangnan University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jia-Xin Li, Macau University of Science and Technology, Macao SAR, China; Le Liu, Southern Medical University, China; Xiping Liu, Gansu University of Chinese Medicine, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Jianwu Xie, <email xlink:href="mailto:xiejw@sust.edu.cn">xiejw@sust.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Intestinal Microbiome, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>04</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1151557</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>01</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Wang, Hou, Cui, Liu, Wang and Xie</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Wang, Hou, Cui, Liu, Wang and Xie</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Non-small cell lung cancer (NSCLC) is one of the most serious diseases affecting human health today, and current research is focusing on gut flora. There is a correlation between intestinal flora imbalance and lung cancer, but the specific mechanism is not clear. Based on the &#x201c;lung and large intestine being interior-exteriorly related&#x201d; and the &#x201c;lung-intestinal axis&#x201d; theory. Here, based on the theoretical comparisons of Chinese and western medicine, we summarized the regulation of intestinal flora in NSCLC by active ingredients of traditional Chinese medicine and Chinese herbal compounds and their intervention effects, which is conducive to providing new strategies and ideas for clinical prevention and treatment of NSCLC.</p>
</abstract>
<kwd-group>
<kwd>NSCLC</kwd>
<kwd>gut microbiome</kwd>
<kwd>lung-gut axis</kwd>
<kwd>TCM</kwd>
<kwd>Chinese herbal compounds</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="91"/>
<page-count count="12"/>
<word-count count="6441"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>In the womb, the fetus begins to develop its gut microbiota, and an estimated 40 trillion microorganisms are considered to reside on and in the human body. The digestive tract, often known as the &#x201c;gut microbiome (GM),&#x201d; contains the most microbial species variety. (<xref ref-type="bibr" rid="B51">Nagasaka et&#xa0;al., 2020</xref>). Although its primary function has been thought to be to protect against pathogen overgrowth in the gut, the gut microbiome appears to play a critical role in the maturation and ongoing education of the host immune response and likely has significant effects in many conditions not typically considered infectious diseases (<xref ref-type="bibr" rid="B17">Fulde and Hornef, 2014</xref>; <xref ref-type="bibr" rid="B36">Kamada et&#xa0;al., 2013</xref>). Intestinal microbiome imbalances, also known as ecological imbalances, have been linked to a variety of illnesses, including cancer, in recent years. Given that the gut microbiome is constantly exposed to a wide spectrum of potential pathogens, it is not surprising that it is vital to the host immune response.</p>
<p>According to the latest data from China&#x2019;s National Cancer Center in 2022, lung cancer is the second most common cancer in humans worldwide, with the highest incidence of morbidity and mortality. NSCLC accounts for more than 80% of all lung cancers, and it is one of the most challenging to treat with a poor response to immune checkpoints (ICIs) in most patients. Interestingly, emerging evidence has suggested that microbiota may also play vital roles in lung cancers at multiple levels (<xref ref-type="bibr" rid="B67">Vernocchi et&#xa0;al., 2020</xref>).</p>
<p>Additionally, there is mounting evidence linking the GM and its metabolome to the response to ICI treatment in NSCLC (<xref ref-type="bibr" rid="B34">Jin et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B3">Botticelli et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B26">Hakozaki et&#xa0;al., 2020</xref>). In fact, the metabolites of the microbes as well as their cells contribute to the stimulation of the immune response. Their interactions stimulate and trigger an immunological response, helping the host immune system combat cancer. The relationship between the gut microbiota and non-small cell lung cancer will therefore be the main topic of this essay.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Close relationship: GM and NSCLC</title>
<sec id="s2_1">
<label>2.1</label>
<title>The overview of GM</title>
<p>A wide variety of microorganisms, including bacteria, fungus, archae, and viruses, live in the complex, dynamic, and geographically heterogeneous ecosystem known as the human GM (<xref ref-type="bibr" rid="B10">Chen et&#xa0;al., 2021b</xref>). The total genetic repertory of all gut microbes is an order of magnitude greater than the genetic repertoire of the human genome, and also encodes many more unique genes than the host genome, and they generate more than 1000 metabolites (<xref ref-type="bibr" rid="B16">Fan and Pedersen, 2021</xref>). It is also referred to as the &#x201c;essential organ&#x201d; of the human body (<xref ref-type="bibr" rid="B14">Ding et&#xa0;al., 2019</xref>). The GM is the body&#x2019;s greatest micro-ecosystem and works in symbiosis with the host to sustain regular physiological functions in a state of dynamic balance (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). Human host receives a number of crucial services from the gut microbiota attests to its significance, including the conversion of indigestible dietary components, the creation of vital vitamins, the elimination of harmful substances, the defeat of infections, the augmentation of the intestinal barrier, and the stimulation and control of the immune system (<xref ref-type="bibr" rid="B28">Heintz-Buschart and Wilmes, 2018</xref>), these are necessary to support normal tissue and organ function. It is generally known that the gut microbiota directly affects both health and disease status. The microbiome has a significant impact on host physiology due to its broad metabolic and synthetic capabilities and its intricate interactions with the formation and control of the host immune system (<xref ref-type="bibr" rid="B68">Walker et&#xa0;al., 2021</xref>). Despite the symbiotic nature of the intestinal host-microbial relationship, the close association of an abundant bacterial community with intestinal tissues poses immense health challenges (<xref ref-type="bibr" rid="B29">Hooper et&#xa0;al., 2012</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The gut microbiome contains the greatest diversity of microbial species, and plays a critical role in the immunoregulation, antibacterial polypeptide, anti-adhesive,the intestinal barrier,and so on.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1151557-g001.tif"/>
</fig>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>The composition of GM</title>
<p>The development of the technique to sequence the bacterial 16S ribosomal RNA gene allowed overall taxonomic assessment of the gut microbiome, and this has dramatically increased our knowledge of the broad variations in microbial composition (<xref ref-type="bibr" rid="B75">Weersma et&#xa0;al., 2020</xref>). The human gut microbiota consists of several types of microbes, including bacteria, archaea, eukarya, viruses, and parasites. More than 1000 species of bacteria have been identified in the human gut, although a person on average only carries 160 species (<xref ref-type="bibr" rid="B2">Berding et&#xa0;al., 2021</xref>). The gut microenvironment mainly favors the growth of bacteria from seven predominant divisions (Firmicutes, Bacteroidetes, Actinobacteria, Fusobacteria, Proteobacteria, Verrucomicrobia, and Cyanobacteria). Among these seven divisions, the Bacteroidetes and Firmicutes constitute more than 90% of the total population (<xref ref-type="bibr" rid="B1">Adak and Khan, 2019</xref>). Studies indicate links between dysbiosis or disturbance in the microbiome and diseases that not only affect the gut but also organs like the lung, thyroid, brain, cardiac, immune system, etc. (<xref ref-type="bibr" rid="B65">Tang et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B31">Hufnagl et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B40">Knezevic et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B58">Rutsch et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B71">Wang et&#xa0;al., 2022a</xref>). The crosstalk between the gut microbiome and distal organs is being increasingly recognized, and host-microbiome interactions are being delineated piece by piece. Gut microbes and their associated metabolites are thought to cause and modulate lung cancer development, albeit influenced by the host genetic make-up and environment. Non-targeted metabolomics approach based on LC-MS can successfully distinguish lung cancer patients from healthy individuals. Also, the microbial diversity in lung cancer patients is significantly higher than that of normal individuals (<xref ref-type="bibr" rid="B87">Zhao et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>The role of GM in NSCLC (Lung-gut axis)</title>    <p>Chinese medicine believes that &#x201c;the lung and large intestine are interior-exteriorly related&#x201d; (<xref ref-type="bibr" rid="B52">Ni et&#xa0;al., 2022</xref>). The hypothesis of the lung-gut axis, which modern medicine has advanced, corresponds to the Chinese medical theory of the &#x201c;lung and large intestine being interior-exteriorly related.&#x201d; The lungs and large intestine can work together to modulate immunity and inflammation through the lung-gut axis, in which the movement of the gut microbiota and metabolites is the most important communication mechanism (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). The lungs and the gut both develop from the same embryo. The gut and the lungs, like all other organs included in the MIS compartments, are mucosally similar, promoting comparable dynamics in the interactions between the immune system and their microbiota. Moreover, they are indirectly connected <italic>via</italic> the circulatory and lymphatic systems (<xref ref-type="bibr" rid="B55">Pizzo et&#xa0;al., 2022</xref>). The lungs do indeed have a specific microbiota. The predominant bacterial phyla in the lungs of healthy subjects are the same as those in the gut. These are mainly Firmicutes (Staphylococcus, La-ctobacillus, and Streptococcus) and Bacteroidetes, followed by Proteobacteria and Actinobacteria (<xref ref-type="bibr" rid="B19">Georgiou et&#xa0;al., 2021</xref>). While lung cancer patients present higher levels of Bacteroidetes, Fusobacteria, Cyanobacteria, Spirochaetes, and Lentisphaerae, and lower levels of Bacteroidetes, Firmicutes, and Verrucomicrobia in their lung and gut microbiota (<xref ref-type="bibr" rid="B12">Corr&#xea;a et&#xa0;al., 2022</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The lungs and large intestine can work together to modulate immunity and inflammation through the lung-gut axis, in which the movement of the gut microbiota and metabolites is the most important communication mechanism. Moreover, they are indirectly connected via the circulatory and lymphatic systems.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1151557-g002.tif"/>
</fig>
<p>Although the gastrointestinal and respiratory systems are separated by physical distance, they share a common embryonic origin and exhibit a striking structural similarity, suggesting the possibility of multimodal interaction between these two tracts. As a result, the gut-lung axis, a new and distinct interaction between the respiratory and gastrointestinal tracts, has been created. According to reports, this two-way regulation of the gut-lung axis organs is accomplished through microbial and immunological processes. A growing body of research suggests that the microbiome is crucial in inflammatory pulmonary disorders such as acute lung injury (ALI) and acute respiratory distress syndrome. Tang et&#xa0;al. discovered that the transition from ulcerative colitis (UC) to colorectal cancer (CRC) significantly altered not only the composition of the gut microbiota and metabolites associated with inflammation but also the lung tissues, which demonstrated that gastrointestinal illnesses can result in pulmonary illnesses (<xref ref-type="bibr" rid="B66">Tang et&#xa0;al., 2022</xref>). Yoon et&#xa0;al. found that the composition of the gut microbiota has a significant impact on BLM-induced wasting and death, suggesting a role for the lung-gut axis in lung injury. They also found that the presence of specific gut commensal microbes may be a risk factor for having more severe inflammatory lung diseases (<xref ref-type="bibr" rid="B81">Yoon et&#xa0;al., 2022</xref>).</p>
<sec id="s2_3_1">
<label>2.3.1</label>
<title>GM regulated inflammation and immune system</title>
<p>It&#x2019;s vital to keep in mind that inflammation can have two opposing impacts on tumors: whereas local inflammation limited to the tumor microenvironment can reduce the tumor, chronic, broad inflammation generally promotes tumor growth. According to preclinical research in mouse models (<xref ref-type="bibr" rid="B59">S&#xe1;nchez-Alcoholado et&#xa0;al., 2020</xref>), GM-mediated colorectal cancer (CRC) and inflammation have a high correlation. Guo et&#xa0;al. revealed that <italic>Ganoderma lucidum</italic> (GLP) decreased colitis and tumorigenesis. The potential explanation is that GLP ameliorated microbiota dysbiosis, increased short-chain fatty acid production, profoundly improved gut barrier function as evidenced by increased numbers of goblet cells, MUC2 secretion, and tight junction protein expressions. Simultaneously, GLP treatment inhibited macrophage infiltration and downregulated IL-1&#x3b2;, iNOS, and COX-2 expressions (<xref ref-type="bibr" rid="B23">Guo et&#xa0;al., 2021a</xref>).</p>
<p>The gut microbiome plays a key role in intestinal permeability and immune regulation. The gut microbiome regulates immune cell populations in part through short-chain fatty acids, which can restore colonic regulatory T cell populations in germ-free mice and signalling <italic>via</italic> Toll-like receptors (TLRs) among other innate and adaptive immune pathways (<xref ref-type="bibr" rid="B41">Leigh and Morris, 2020</xref>). Peng et&#xa0;al. recruited 74 patients with advanced-stage gastrointestinal (GI) cancer receiving anti-PD-1/PD-L1 treatment and collected their fecal samples prior to and during immunotherapy, along with clinical evaluations. They revealed an elevation of the <italic>Prevotella/Bacteroides</italic> ratio in patients, with a preferred response to antiPD-1/PD-L1 treatment and a particular subgroup of responders harboring a significantly higher abundance of <italic>Prevotella, Ruminococcaceae</italic>, and <italic>Lachnospiraceae</italic> (<xref ref-type="bibr" rid="B54">Peng et&#xa0;al., 2020</xref>). Huang et&#xa0;al. found Ginseng polysaccharides (GPs) increased the antitumour response to &#x3b1;PD-1 monoclonal antibody (mAb) by increasing the microbial metabolites valeric acid and decreasing L-kynurenine, as well as the ratio of kynurenine/tryptophan, which contributed to the suppression of regulatory T cells and induction of Teff cells after combination treatment. And the microbial analysis indicated that the abundance of <italic>Parabacteroides distasonis and Bacteroides vulgatus</italic> was higher in responders to anti-PD-1 blockade than in non-responders in the clinic(<xref ref-type="bibr" rid="B30">Huang et&#xa0;al., 2022</xref>). And a clinical study of 37 patients with advanced NSCLC in China reveal strong correlation between gut microbiome diversity and the responses to anti-PD-1 immunotherapy. Patients with a favorable gut microbiome exhibit enhanced memory T cell and natural killer cell signatures in the periphery (<xref ref-type="bibr" rid="B34">Jin et&#xa0;al., 2019</xref>).</p>
</sec>
<sec id="s2_3_2">
<label>2.3.2</label>
<title>Metabolites of GM in NSCLC</title>
<p>The short-chain fatty acids (SCFAs), which are the major metabolic products of the GM from dietary fiber (especially in the case of a high-fiber diet), are key mediators of the host&#x2013;microbiome interaction and perform countless functions with localized and systemic effects. Main SCFAs with total intestinal concentrations exceeding 100 mM include propionate, acetate, and butyrate (<xref ref-type="bibr" rid="B50">Mirzaei et&#xa0;al., 2021</xref>). The basic function of these fatty acids is to provide energy. SCFAs also act as signaling molecules by mediating metabolic processes and immune responses, and various studies have proven their impressive anti-inflammatory action and antitumor potential. One study showed that sodium butyrate affects proliferation and migration of A549 cells by activating the TNF receptor-associated factor 6 (TRAF6)-thioredoxin-interacting protein (TXNIP) pathway, suggesting that sodium butyrate has an effective therapeutic effect on lung adenocarcinoma. (<xref ref-type="bibr" rid="B77">Xiao et&#xa0;al., 2020</xref>). It was also found that sodium butyrate and docetaxel alone, respectively, inhibited proliferation and promoted apoptosis in A549 cells <italic>in vitro</italic> and <italic>in vivo</italic>. Furthermore, the combined therapy decreased protein expression of Ki-67, CDK1, CDK2, Cyclin D1, Bcl-2, and Survivin and increased protein expression of Cyclin A, p21, Bax and cleaved-Caspase 3 (<xref ref-type="bibr" rid="B6">Chen et&#xa0;al., 2020b</xref>). Chen et&#xa0;al. reported that propionate and butyrate produced by gut microbiota after probiotic supplementation can attenuate the lung metastasis of melanoma cells in mice (<xref ref-type="bibr" rid="B11">Chen et&#xa0;al., 2021a</xref>). Sodium propionate (SP) inhibited lung cancer cell proliferation by inducing cell apoptosis and cell cycle arrest, especially in the G2/M phase (<xref ref-type="bibr" rid="B38">Kim et&#xa0;al., 2019</xref>).</p>
</sec>
<sec id="s2_3_3">
<label>2.3.3</label>
<title>GM involved in the treatment of NSCLC</title>
<p>Unusual bacterial clusters were discovered in the NSCLC patients in an observational investigation with exploratory GM analysis, and the individuals who did not have cachexia were enriched with healthy bacteria at the genus level, including Eubacterium, Anaerostipes, and Blautia (<xref ref-type="bibr" rid="B25">Hakozaki et&#xa0;al., 2022</xref>). Akkermansia bacteria, specifically Akkermansia mucinifla, is now being found in relation to supporting therapy and markers for an immunotherapy response in cancer patients. It has been shown that this bacterium improves response to treatment in NSCLC patients receiving immune checkpoint inhibitors (ICIs). In the 47 NSCLC patients studied by Grenda et&#xa0;al., patients with disease stabilization and partial immunotherapy responses had a higher percentage of Akkermansiaceae than patients with cancer progression. Additionally, they discovered that patients with squamous cell carcinoma had more Akkermansiaceae than those with adenocarcinoma. As a result, they suggested that Akkermansiaceae may serve as a supportive marker for NSCLC patients&#x2019; immunotherapy responses (<xref ref-type="bibr" rid="B21">Grenda et&#xa0;al., 2022</xref>). An animal research indicated that Akkermansia muciniphila (Akk) combining with cisplatin (CDDP) slowed down the growth of tumor volume and improved the changes in tumor pathomorphology and was related to those pathways, including the cytokine-cytokine receptor interaction, Th17 cell differentiation, FOXO, JAK-STAT, and PI3K-Akt signaling pathways (<xref ref-type="bibr" rid="B8">Chen et&#xa0;al., 2020c</xref>).</p>
<p>Cancer immunotherapy has become highly successful against an array of distinct hematological and solid metastatic malignancies. Immune checkpoint inhibitors (ICIs) targeting the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) axis induce sustained clinical responses in a measure of cancer patients. Routy et&#xa0;al. found that primary resistance to ICIs can be attributed to abnormal gut microbiome composition (<xref ref-type="bibr" rid="B57">Routy et&#xa0;al., 2018</xref>). Their results prove that Fecal microbiota transplantation (FMT) from cancer patients who responded to ICIs into germ-free or antibiotic-treated mice ameliorated the antitumor effects of PD-1 blockade, whereas FMT from nonresponding patients failed to do so. Drug regimens for many tumors also relate to intestinal microecology, such as one of the most popular chemotherapy drugs, paclitaxel (PTX), which was used to treat a variety of tumor types but whoes debilitating side effects included gastrointestinal and behavioral disorders, restricting its use while a 30-day sodium butyrate (BuNa) pre-treatment repaired the altered gut barrier integrity and microbiota composition caused by the PTX. These findings suggest that dietary supplementation with this secure postbiotic may be taken into account for treating PTX-induced central side effects when treating cancer (<xref ref-type="bibr" rid="B13">Cristiano et&#xa0;al., 2022</xref>). In addition, probiotic use was linked to better clinical outcomes in patients with advanced or recurrent NSCLC who received anti-PD-1 monotherapy, according to a multicenter retrospective analysis (<xref ref-type="bibr" rid="B64">Takada et&#xa0;al., 2021</xref>), which indicates that probiotics may be an superior option for NSCLC patients who receive ICIs.</p>
</sec>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>Traditional Chinese medicines and GM</title>
<sec id="s3_1">
<label>3.1</label>
<title>Active components of TCMs</title>
<sec id="s3_1_1">
<label>3.1.1</label>
<title>Polysaccharide</title>
<p>Drug therapy using natural substances is currently considered a promising future alternative to traditional medicine. As an important class of biologically active natural products, polysaccharides from TCM play an important role in the field of medicine, including gut microbiome regulation (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>), immune regulation, as well as anti-tumor, anti-oxidation, etc. (<xref ref-type="bibr" rid="B82">Yu et&#xa0;al., 2018</xref>). Luo et&#xa0;al., who demonstrated that <italic>Polygonatum sibiricum</italic> polysaccharides-1 (PSP-1) reconstructed the gut microbiota composition, including reducing the relative abundance of Helicobacter, and increasing Akkermansia muciniphila, and revealed that PSP-1 may improve the inflammatory environment and reduce Amyloid-&#x3b2; (A&#x3b2;) deposition in the intestine of 5xFAD mice by acting on the bacteria (<xref ref-type="bibr" rid="B49">Luo et&#xa0;al., 2022</xref>). Sun et&#xa0;al. found that a water-insoluble polysaccharide (WIP) isolated and identified from the <italic>Poria cocos</italic> mushroom significantly enhanced the butyrate-producing bacteria Lachnospiracea and Clostridium. It was also demonstrated that WIP treatment increased butyrate-producing in the gut, maintained intestinal integrity, and reducted of endoxemia, and activated the intestinal PPAR-&#x3b3; pathway (<xref ref-type="bibr" rid="B63">Sun et&#xa0;al., 2019</xref>). Some scholars have carried out related research on <italic>Astragalus</italic> polysaccharide (APS). Zhong et&#xa0;al. indicated that <italic>Astragalus</italic> mongholicus polysaccharides (mAPS) significantly reduced the <italic>Firmicutes</italic> to <italic>Bacteroidetes</italic> (F/B) ratio and increased the abundance of <italic>Proteobacteria</italic> and <italic>Episilonbacteria.</italic> And mAPS significantly decreased the expression of colonic G-protein-coupled receptors (GPR) 41 and 43, but it had little effect on the profile of fecal short-chain fatty acids (SCFAs) (<xref ref-type="bibr" rid="B89">Zhong et&#xa0;al., 2022</xref>). Additionally, Liu et&#xa0;al. demonstrated that APS significantly regulated gut microbial dysbiosis while also recovering the abnormality of fecal metabolism, including glycolysis/gluconeogenesis metabolism and pyruvate metabolism (<xref ref-type="bibr" rid="B46">Liu et&#xa0;al., 2022</xref>). Ying et&#xa0;al. aimed to evaluate the protective effect of Cordyceps sinensis polysaccharides (CSP). They found that CSP could increase the abundance of probiotics and decrease pathogenic bacteria. It reduced the side effects of cyclophosphamide (Cy) on intestinal mucosal immunity and gut microbiota (<xref ref-type="bibr" rid="B80">Ying et&#xa0;al., 2020</xref>). Turmeric polysaccharides (TPS) were found to increase the abundance of probiotics, such as Lactobacillus and Clostridium-UCG-014, and exert their gut barrier functions through the activation of the aryl hydrocarbon receptor (AhR) to upregulate epithelial tight junction proteins (<xref ref-type="bibr" rid="B78">Yang et&#xa0;al., 2021</xref>). Jing et&#xa0;al. used <italic>Codonopsis pilosula</italic> polysaccharides to treat colitis in model mice with Dextran Sulfate Sodium (DSS)-Induced, and they found that this medicine could stimulate the growth of important probiotics, inhibit the growth of pathogenic bacteria, and enhance the production of short-chain fatty acids (<xref ref-type="bibr" rid="B35">Jing et&#xa0;al., 2018</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>The polysaccharides from TCM regulated gut microbiome.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Bioactive ingredients</th>
<th valign="top" align="center">Detection method</th>
<th valign="top" align="center">Gut microbiota</th>
<th valign="top" align="center">Metabolites</th>
<th valign="top" align="center">mechanism</th>
<th valign="top" align="center">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<italic>Polygonatum sibiricum</italic> polysaccharides (PSPs)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">
<italic>Helicobacter</italic>&#x2193;, <italic>Akkermansia muciniphila</italic>&#x2191;.</td>
<td valign="top" align="left">A&#x3b2;&#x2193;, occludin&#x2191;, ZO-1&#x2191;, TNF&#x3b1;&#x2193;, IL-6&#x2193;.</td>
<td valign="top" align="left">Reduces intestinal permeability.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B49">Luo et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>Poria cocos</italic> mushroom polysaccharides</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">
<italic>Lachnospiracea</italic>&#x2191;, <italic>Clostridium</italic>&#x2191;.</td>
<td valign="top" align="left">Butyrate&#x2191;, TNF&#x3b1;&#x2193;, occludin&#x2191;, ZO-1&#x2191;, LPS&#x2193;, PPAR-&#x3b3;&#x2191;.</td>
<td valign="top" align="left">Maintains intestinal integrity and reduction of endoxemia.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B63">Sun et&#xa0;al., 2019</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Astragalus mongholicus polysaccharides(mAPS)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Proteobacteria&#x2191;, Epsilonbacteriathe&#x2191;, Bacteroidetes (F/B) ratio&#x2193;.</td>
<td valign="top" align="left">Occludin&#x2191;, ZO-1&#x2191;, LPS&#x2193;, TLR4&#x2193;, P-NF-&#x3ba;B&#x2193;, NLRP3&#x2193;, GRP43&#x2193;, GPR41&#x2193;.</td>
<td valign="top" align="left">Modulating the gut microbiota and SCFA-GPR signaling pathways.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B89">Zhong et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Astragalus polysaccharides (APS)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Blautia&#x2191;, Lactobacillus&#x2193;.</td>
<td valign="top" align="left">acetate&#x2193;, butyrate&#x2193;, propionate&#x2193;.</td>
<td valign="top" align="left">regulating glycolysis /gluconeogenesis metabolism and pyruvate metabolism.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B46">Liu et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>Cordyceps sinensis</italic> polysaccharides (CSP)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Lactobacillus&#x2191;, Bifidobacterium&#x2191;, Bacteroides&#x2191;, Clostridium&#x2193;, Flexispira&#x2193;.</td>
<td valign="top" align="left">acetic acid&#x2191;, propionic acid&#x2191;, butyric acid&#x2191;, valeric acid&#x2191;, total SCFAs&#x2191;.</td>
<td valign="top" align="left">Recover Cy-induced intestinal mucosal immunosuppression</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B80">Ying et&#xa0;al., 2020</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">turmeric polysaccharides (TPS)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Clostridia-UCG-014&#x2191;, Lactobacillus&#x2191;, Akkermansia&#x2191;, Bacteroides&#x2191;, Firmicutes&#x2193;</td>
<td valign="top" align="left">occludin&#x2191;, ZO-1&#x2191;, acetic acid&#x2191;, butyric acid&#x2191;, propanoic acid&#x2191;, valeric acid&#x2191;, total acid&#x2191;, I3AM&#x2193;, tryptophan&#x2193;, IAA&#x2191;, IAAId&#x2191;.</td>
<td valign="top" align="left">modulating the gut microbiota, improving microbial metabolites and gut barrier function.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B78">Yang et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>Codonopsis pilosula</italic> polysaccharides</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">
<italic>Bifidobacterium spp.</italic>&#x2191;, <italic>Lactobacillus spp.</italic>&#x2191;, <italic>Akkermansia spp.</italic>&#x2191;, <italic>Desulfovibrio spp.</italic>&#x2193;, <italic>Alistipes spp.</italic>&#x2193;, <italic>Helicobacter spp.</italic>&#x2193;.</td>
<td valign="top" align="left">acetic acid&#x2191;, butyric acid&#x2191;, propionic acid&#x2191;, isobutyric acid&#x2191;, isovaleric acid&#x2191;.</td>
<td valign="top" align="left">stimulated the growth of important probiotics, inhibited the growth of pathogenic bacteria, enhanced the production of short-chain fatty acids,</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B35">Jing et&#xa0;al., 2018</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2191; increase. &#x2193; decrease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_1_2">
<label>3.1.2</label>
<title>Saponin</title>
<p>Saponins, glycosides widely distributed in TCM, include a diverse group of compounds characterized by their structure, which contains a steroidal or triterpenoid aglycone and one or more sugar chains (<xref ref-type="bibr" rid="B22">G&#xfc;&#xe7;l&#xfc;-&#xdc;st&#xfc;nda&#x11f; and Mazza, 2007</xref>). Which possess a multitude of biological activities such as antitumor activities, antimicrobial activity, antiviral activity, etc. (<xref ref-type="bibr" rid="B39">Kimura et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B61">Sharma et&#xa0;al., 2021</xref>). In recent years, it has been found that the components of saponins from TCM play a role in disease treatment by regulating intestinal flora (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). Akebia saponin D (ASD) has been shown to treat hyperlipidemic rats induced by a high-fat diet by regulating the intestinal microbiota, and it could partially recover both metabolism dysfunction and the intestinal environment through several metabolic pathways and modulation of the microbial community (<xref ref-type="bibr" rid="B90">Zhou et&#xa0;al., 2019</xref>). Guo et&#xa0;al. demonstrated that ginsenoside Rg1 possessed a neuroprotective effect on tree shrew model for Alzheimer&#x2019;s disease, and may have a close association with the microbiota of the large intestine by significantly reducing the abundance of Bacteroidetes (<xref ref-type="bibr" rid="B24">Guo et&#xa0;al., 2021b</xref>). Alike, Chen et&#xa0;al. found that ginsenoside Rg1 could mitigate morphine dependence <italic>via</italic> regulation of gut microbiota and inhibit gut microbiota-derived tryptophan metabolism and reduce serotonin (<xref ref-type="bibr" rid="B7">Chen et&#xa0;al., 2022a</xref>). <italic>Astragalus</italic> has the effects of anti-tumor, lowering blood pressure, lowering blood sugar, and improving human immunity. Gong et&#xa0;al. found in animal experiments that <italic>Astragaloside</italic> IV plays a hypoglycemic role by regulating intestinal flora and AMPK/SIRT1 and PI3K/AKT pathways (<xref ref-type="bibr" rid="B20">Gong et&#xa0;al., 2021</xref>). On the other hand, intestinal microorganisms can also affect the metabolism of saponins <italic>in vivo</italic> (<xref ref-type="bibr" rid="B15">Dong et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B83">Zhang et&#xa0;al., 2018</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>The saponins from TCM regulated gut microbiome.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Bioactive ingredients</th>
<th valign="top" align="center">Detection method</th>
<th valign="top" align="center">Gut microbiota</th>
<th valign="top" align="center">Metabolites</th>
<th valign="top" align="center">mechanism</th>
<th valign="top" align="center">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">akebia saponin D (ASD)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Norank_f_Bacteroidales_S24-7 gro up&#x2191;, Lachnospiraceae_NK4A136_ group&#x2191;, Prevotella_9&#x2191;, Desulfovibri o&#x2191;, Ruminococcus_1&#x2191;, <italic>Eubacteriu m_coprostanoligenes</italic>_group&#x2191;, Lactobacillus&#x2193;, Blautia&#x2193;.</td>
<td valign="top" align="left">1-phenylethylamine&#x2191;, deoxycholic acid&#x2191;, L-glutamate&#x2193;, <italic>cis</italic>-9-palmitoleic acid&#x2193;.</td>
<td valign="top" align="left">The correlation between fecal metabolites and microbiota.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B90">Zhou et&#xa0;al., 2019</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Ginsenosides Re</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Prevotella&#x2191;, Lactobacillus&#x2193;, Bacteroides&#x2193;.</td>
<td valign="top" align="left">Glycosidase activities&#x2191;.</td>
<td valign="top" align="left">Ginsenoside Re and gut microbiota regulated each other.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B83">Zhang et&#xa0;al., 2018</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Ginsenoside Rb1</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Blautia&#x2193;, Allobaculum&#x2193;, Turicibacter&#x2191;.</td>
<td valign="top" align="left">Phosphatidylcholine (PC)&#x2191;.</td>
<td valign="top" align="left">Regulated intestinal flora to increase their PC content.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B44">Lianqun et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Ginsenoside Rg1</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Lactobacillus salivarius&#x2191;, Firmicutes/Bacteroides ratio&#x2191;, Bacteroides&#x2193;.</td>
<td valign="top" align="left">Bcl-2&#x2191;, Bax&#x2193;.</td>
<td valign="top" align="left">Improved the microbiota imbalance of the large intestine.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B24">Guo et&#xa0;al., 2021b</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Ginsenoside Rg1</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Bacteroidetes&#x2191;, Firmicutes&#x2191;, Cyanobacteria&#x2193;, Proteobacteria&#x2193;.</td>
<td valign="top" align="left">5-HTR1B&#x2193;, 5-HTR2A&#x2193;, serotonin&#x2193;.</td>
<td valign="top" align="left">Manipulation of the gut microbial composition and tryptophan metabolite.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B7">Chen et&#xa0;al., 2022a</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Astragaloside IV</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Anaerobacter&#x2191;, Romboutsia&#x2191;, Alkalibacteria&#x2191;, Canadidatus stoquefichus&#x2191;, Oligobacterium&#x2191;, Brautella&#x2191;, Erysipelatoclostridum&#x2191;, Bacteroides&#x2193;, Oscillibacter&#x2193;, Parabacteroides&#x2193;, Roseburia&#x2193;, Muribaculum&#x2193;.</td>
<td valign="top" align="left">butyric acid&#x2191;.</td>
<td valign="top" align="left">Regulating gut microbiota and AMPK/SIRT1 and PI3K/AKT signaling pathways.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B20">Gong et&#xa0;al., 2021</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2191; increase. &#x2193; decrease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_1_3">
<label>3.1.3</label>
<title>Flavonoids</title>
<p>
<italic>Smilax china L</italic>., commonly known as &#x201c;Baqia&#x201d; is not just a comestible; it was also used as traditional herbal medicine in China. It contains multifarious naturally bioactive compounds, such as flavonoids, polyphenols, and steroidal saponins (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). Li et&#xa0;al. investigated the effects of <italic>Smilax</italic> chinensis <italic>L</italic>. flavonoid (SCF) on obesity and changes in gut microbiota. Their results found that SCF modulated the composition of gut microbiota and decreased the production of SCFAs, resulting in reduced energy absorption and subsequent weight loss in the mice (<xref ref-type="bibr" rid="B43">Li et&#xa0;al., 2021</xref>). The findings of Wang et&#xa0;al. provide evidence that <italic>Acanthopanax senticosus</italic> total flavonoids (ASTFs) have significant anti-inflammatory properties on LPS-induced intestinal inflammation, preserve the integrity of the intestinal barrier, and regulate gut microbiota homeostasis (<xref ref-type="bibr" rid="B74">Wang X. et&#xa0;al., 2022</xref>). Baicalin has a variety of pharmacological effects, including anti-inflammation, anti-infection, anti-apoptosis, anti-allergy, and so on. Some scholars have found that baicalin rebalances the gut microbial composition pattern impaired by ionizing radiation (IR) and alleviates IR-induced apoptosis of the gut microbiota (<xref ref-type="bibr" rid="B69">Wang et&#xa0;al., 2020b</xref>). In addition, other scholars have also done research on baicalin; they found that baicalin can improve abnormal metabolism and gut microbiota in high-fat diet (HFD)-induced metabolic syndrome (MetS) in mice (<xref ref-type="bibr" rid="B45">Lin et&#xa0;al., 2022</xref>). Glycosides and flavonoids from <italic>P. thomsonii</italic> leaves (PL) alleviated type 2 diabetes in high-fat diet plus streptozotocin-induced mice. This process may be associated with the biological activity that Glycosides and flavonoids from PL could increase intestinal probiotics to improve metabolic disorders caused by diabetes and decrease the level of Clostridium celatum to relieve inflammation (<xref ref-type="bibr" rid="B86">Zhang et&#xa0;al., 2022</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>The flavonoids from TCM regulated gut microbiome.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Bioactive ingredients</th>
<th valign="top" align="center">Detection method</th>
<th valign="top" align="center">Gut microbiota</th>
<th valign="top" align="center">Metabolites</th>
<th valign="top" align="center">mechanism</th>
<th valign="top" align="center">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<italic>Smilax china L.</italic> flavonoid (SCF)</td>
<td valign="top" align="left">16S rDNA gene sequencing.</td>
<td valign="top" align="left">unclassified_g_Akkermansia&#x2191;, uncultured_bacterium_g_Desulfovibrio&#x2193;, uncultured_bacterium_g_ Faecalibaculum&#x2193;, unclassified _g_norank_ f_Lachnospiraceae&#x2193;, uncalssified_g_Lachnoclostridium&#x2193;, uncalssified_g_Lactobacilus&#x2193;.</td>
<td valign="top" align="left">propionic acid (PA) &#x2193;, butyric acid (BA) &#x2193;, isobutyric acid (IBA) &#x2193;, valeric acid (VA) &#x2193;, isovaleric acid (IVA) &#x2193;.</td>
<td valign="top" align="left">Modulating the composition of gut microbiota and decreased the production of SCFAs.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B43">Li et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>Acanthopanax senticosus</italic> total flavonoids (ASTFs)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Ruminiclostridium-9&#x2191;, Bacteroides&#x2193;, Alistipes&#x2193;, Parabacteroides&#x2193;.</td>
<td valign="top" align="left">Goblet cells (GCs)&#x2191;, inflammatory cells&#x2193;, the small intestine tissue returned to normal.</td>
<td valign="top" align="left">Preserving the integrity of the intestinal barrier and regulating gut microbiota homeostasis.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B73">Wang et&#xa0;al., 2022b</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Baicalin</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Lactobacillus&#x2191;, Prevotellaceae_UCG-001&#x2191;, Bacteroides&#x2193;, Alistipes&#x2193;, Parabacteroides&#x2193;, Ruminococcaceae_UCG-014&#x2193;.</td>
<td valign="top" align="left">Caspase3&#x2193;. Bcl-xl&#x2193;. Bax&#x2193;, Caspase8&#x2193;, p53&#x2193;.</td>
<td valign="top" align="left">Alleviating ionizing radiation (IR) induced apoptosis of gut microbiota.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B69">Wang K. et&#xa0;al., 2020</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Baicalin</td>
<td valign="top" align="left">16S rDNA gene sequencing.</td>
<td valign="top" align="left">Streptococcus&#x2193;, Lactococcusm&#x2193;, Ruminococcus&#x2193;, Oscillospira&#x2193;, Lactobacillus&#x2193;, Mucispirillum&#x2193;, Bacteroides&#x2193;, Odoribacter&#x2193;, Butyricimonas&#x2193;.</td>
<td valign="top" align="left">Regulated TCA cycle and Aminoacyl-tRNA biosynthesis.</td>
<td valign="top" align="left">Regulating metabolites and gut microbiota.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B45">Lin et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Glycosides and flavonoids from <italic>P. thomsonii</italic> leaves</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Lactobacillus&#x2191;, Clostridium celatum&#x2193;, Firmicutes/Bacteroidetes (F/B) &#x2193;.</td>
<td valign="top" align="left">activated carbohydrate biosynthesis and glycolysis.</td>
<td valign="top" align="left">Improved metabolic disorders and relieved inflammation.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B86">Zhang et&#xa0;al., 2022</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2191; increase. &#x2193; decrease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_1_4">
<label>3.1.4</label>
<title>Alkaloid</title>
<p>Alkaloid is an important natural organic compound that is one of the important effective components in Chinese herbal medicine. It has a variety of biological activities and pharmacological effects, mainly antibacterial, anti-inflammatory, liver protection, and nervous system effects. It has been confirmed that the components of alkaloids from TCM play a role in disease treatment by regulating gut microbiota (<xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). Zhang et&#xa0;al. confirmed that alkaloids from <italic>Sophora alopecuroides</italic> L. can improve depression in mice; this biological phenomenon is associated with modulating gut microbiota and gut microbiota directly participating in the metabolic process of the host (<xref ref-type="bibr" rid="B84">Zhang et&#xa0;al., 2021a</xref>). Berberine, the major active ingredient of the Chinese herb Coptis chinensis (Huang-Lian), has been used by clinicians to treat bacterial diarrhea. Zhang et&#xa0;al. found that berberine can alter the functions and metabolites of the gut microbiota. And Zhao et&#xa0;al. used berberine to treat a mouse model with acute graft-versus-host disease (aGVHD); their results suggest that the berberine could remodel gut microbiota and prevent colonic barrier impairment (<xref ref-type="bibr" rid="B88">Zhao et&#xa0;al., 2022</xref>). Other scholars also found that berberine increased the abundance of beneficial bacteria that can produce SCFAs, and the SCFAs can directly alleviate the accumulation of uric acid (<xref ref-type="bibr" rid="B60">Shan et&#xa0;al., 2022</xref>). Song et&#xa0;al. demonstrated that sinomenine can inhibit the inflammatory response by modulating gut microbiota and restoring the intestinal barrier <italic>via</italic> the aryl hydrocarbon receptor/Nrf2-dependent pathway (<xref ref-type="bibr" rid="B62">Song et&#xa0;al., 2021</xref>).</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>The alkaloid from TCM regulated gut microbiome.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Bioactive ingredients</th>
<th valign="top" align="center">Detection method</th>
<th valign="top" align="center">Gut microbiota</th>
<th valign="top" align="center">Metabolites</th>
<th valign="top" align="center">mechanism</th>
<th valign="top" align="center">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Alkaloids from <italic>Sophora alopecuroides</italic> L.</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Lactobacillus&#x2191;, Oscillospira&#x2193;, Desulfovibrio&#x2193;.</td>
<td valign="top" align="left">Fatty acid biosynthesis, lipoic acid metabolism, vitamin B6 metabolism, and so on.</td>
<td valign="top" align="left">Gut microbiota directly participates in the metabolic process of the host.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B43">Zhang et&#xa0;al., 2021b</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Berberine</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Anaerostipes&#x2191;, Eubacterium&#x2191;, Lachnoclostridium&#x2191;, Eisenbergiella&#x2191;.</td>
<td valign="top" align="left">acetate&#x2191;, propionate&#x2191;, total SCFA&#x2191;, valerate &#x2193;, isobutyrate&#x2193;.</td>
<td valign="top" align="left">Altered the functions and metabolites of the gut microbiota.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B43">Zhang et&#xa0;al., 2021a</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Berberine</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Adlercreutzia&#x2191;, Dorea&#x2191;, Sutterella&#x2191;, Plesiomonas&#x2191;, Lactobacillus&#x2191;.</td>
<td valign="top" align="left">Claudin-1&#x2191;, Claudin-2&#x2191;, Occludin&#x2191;, ZO1&#x2191;, LBP&#x2193;.</td>
<td valign="top" align="left">Remodelled gut microbiota and prevented the colonic barrier impairment</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B43">Zhao et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Berberine</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Coprococcus&#x2191;, Bacteroides&#x2191;, Akkermansia&#x2191;, Prevotella&#x2191;.</td>
<td valign="top" align="left">SCFAs&#x2191;.</td>
<td valign="top" align="left">Beneficial bacteria produced SCFAs, SCFAs alleviated accumulation of uric acid.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B43">Shan et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Sinomenine</td>
<td valign="top" align="left">16S rDNA gene sequencing.</td>
<td valign="top" align="left">Bacteroidetes&#x2191;, Proteobacteria&#x2193;,<break/>Prevotellaceae UCG-001&#x2191;, Escherichia-Shigella&#x2193;.</td>
<td valign="top" align="left">Occludin&#x2191;, ZO1&#x2191;, Claudin-1&#x2191;, serum LPS&#x2193;, CYP1A1&#x2191;, Ah<break/>R &#x2191;, NQO-1 &#x2191;, HO-1&#x2191;.</td>
<td valign="top" align="left">Modulated gut microbiota and restored intestinal barrier via aryl hydrocarbon receptor/ Nrf2-dependent pathway.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B43">Song et&#xa0;al., 2021</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2191; increase. &#x2193; decrease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Chinese herbal compound.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Bioactive ingredients</th>
<th valign="top" align="center">Detection method</th>
<th valign="top" align="center">Gut microbiota</th>
<th valign="top" align="center">Metabolites</th>
<th valign="top" align="center">mechanism</th>
<th valign="top" align="center">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<italic>Astragalus membranaceus</italic> and <italic>Salvia miltiorrhiza</italic> (AS)</td>
<td valign="top" align="left">16S rDNA gene sequencing.</td>
<td valign="top" align="left">Lactobacillus&#x2191;, Akkermansia&#x2191;, Firmicum to Bacteroides (F/B) &#x2193;.</td>
<td valign="top" align="left">Butyric acid&#x2191;, lactic acid&#x2191;, ZO-1&#x2191;.</td>
<td valign="top" align="left">Restored the intestinal barrier and flora structure, increased the butyric acid and lactic acid.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B27">Han et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">FuZhengHuaYuJiangZhuTongLuoFang prescription (FZHY)</td>
<td valign="top" align="left">16S rDNA gene sequencing.</td>
<td valign="top" align="left">g_Monoglobus&#x2193;, g_Papillibacter&#x2193;, g_Eubacterium_nodatum&#x2193;, g_ Family_XIII_AD3011&#x2193;.</td>
<td valign="top" align="left">ZO-1&#x2191;, occludin&#x2191;, claudin-1&#x2191;.</td>
<td valign="top" align="left">Reduced the colonic epithelial barrier damages.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B6">Chen et&#xa0;al., 2022b</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">FuFang Zhenshu TiaoZhi(FTZ)</td>
<td valign="top" align="left">16S rDNA gene sequencing.</td>
<td valign="top" align="left">Bacteroidetes&#x2193;, Proteobacteria&#x2193;, Firmicutes&#x2191;, F/B ratio&#x2191;, Prevotellaceae_UCG-001&#x2191;.</td>
<td valign="top" align="left">TNF-&#x3b1;&#x2193;, IL-6&#x2193;.</td>
<td valign="top" align="left">Modulated the balance of intestinal microecology, restored inflammation.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B48">Luo et&#xa0;al., 2020</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Painong-San extract (PNS)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Romboutsia&#x2191;, Lactobacillus&#x2191;, Bifidobacterium&#x2191;, Akkermansia&#x2191;, Oscillospiraceae&#x2193;, Helicobacter&#x2193;.</td>
<td valign="top" align="left">claudin-1&#x2191;, occludin&#x2191;, ZO-1&#x2191;.</td>
<td valign="top" align="left">Regulated of gut microbi ota, improved intestinal barrier function.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B70">Wang et&#xa0;al., 2022a</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Xuanbai Chengqi decoction (XBCQ)</td>
<td valign="top" align="left">16S rRNA gene sequencing.</td>
<td valign="top" align="left">Gordonibacter&#x2191;, Akkermansia&#x2191;, Streptococcus&#x2193;, Marvinbryantia&#x2193;.</td>
<td valign="top" align="left">Rectifyed the Th17/ Treg imbalance, TNF-&#x3b1;&#x2193;, IL-1&#x3b2;&#x2193;, MMP-9&#x2193;.</td>
<td valign="top" align="left">Reshaped the gut microbiota and improved the Th17/Treg balance.</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B74">Wang et&#xa0;al., 2021b</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2191; increase. &#x2193; decrease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Chinese herbal compound</title>
<p>Traditional Chinese medicine compound usually consists of two or more medicinal flavors, has relatively prescriptive processing methods and use methods, and is designed for relatively certain diseases and syndromes. At present, many compounds have been applied to the treatment of gut microbiota (<xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref>). For example, the combination of <italic>Astragalus</italic> membranaceus and <italic>Salvia</italic> miltiorrhiza (AS) is an effective prescription that is widely used to treat chronic kidney disease (CKD) clinically in traditional Chinese medicine. AS could alleviate renal fibrosis and metabolism through the &#x201c;gut-kidney axis&#x201d;, Han et&#xa0;al. found that AS restored the intestinal barrier and flora structure and increased butyric acid and lactic acid to exert the above effects (<xref ref-type="bibr" rid="B27">Han et&#xa0;al., 2021</xref>). Zhao et&#xa0;al. also found that the Chinese herb FuZhengHuaYuJiangZhuTongLuoFang prescription (FZHY) can effectively treat CKD; the pathways included the regulation of gut microbiota (<xref ref-type="bibr" rid="B9">Chen et&#xa0;al., 2022b</xref>). Other researchers found that Chinese herbs have an anti-aging effect. Luo et&#xa0;al. revealed that FuFang Zhenshu TiaoZhi (FTZ) can moderately correct the aging process, which may be related to modulating the balance of intestinal microecology and restoring inflammation (<xref ref-type="bibr" rid="B48">Luo et&#xa0;al., 2020</xref>). Painong Powder was developed by Zhongjing Zhang in the Han Dynasty and has been widely used to treat ulcerative colitis (UC) in China for thousands of years. The experimental research confirmed that Painong-San (PNS) extract alleviates colitis in mice by modulating gut microbiota and restoring intestinal barrier function (<xref ref-type="bibr" rid="B70">Wang K. et&#xa0;al., 2022</xref>). Xuanbai Chengqi decoction (XBCQ) is a representative traditional Chinese medicine prescription used by Wu Jutong in the Qing Dynasty. It has been widely used to treat a variety of common respiratory diseases in China. There are also scholars studying his role in the regulation of intestinal flora. Wang et&#xa0;al. demonstrated that XBCQ could alleviate chronic obstructive pulmonary disease (COPD) exacerbations by reshaping the gut microbiota and improving the Th17/Treg balance (<xref ref-type="bibr" rid="B72">Wang et&#xa0;al., 2021b</xref>). And the studies have shown that Yangyin Qingfei decoction can effectively improve the skin damage of lung cancer patients after radiotherapy, help the growth and propagation of beneficial bacteria in the intestinal tract of lung cancer patients, and regulate the structural balance of intestinal flora (<xref ref-type="bibr" rid="B53">Pan and Zhang 2023</xref>).</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Effection of TCMs on prevention and treatment of NSCLC</title>
<sec id="s4_1">
<label>4.1</label>
<title>Active components of TCM</title>
<p>Ganoderma lucidum polysaccharides (GLP) were derived from <italic>Ganoderma lucidum</italic> (lingzhi in Chinese). Gynostemma pentaphyllum saponins (GpS) are derived from <italic>Gynostemma pentaphyllum.</italic> Both are valuable traditional Chinese medicines. Khan et&#xa0;al. provide strong evidence that the cancer-preventive and therapeutic functions of GpS and GLP are through the dynamic modulation of GM and host immune responses. The specific performance is an improved inflamed gut barrier and promoted short-chain fatty acids (SCFAs) producing bacteria (<xref ref-type="bibr" rid="B37">Khan et&#xa0;al., 2019</xref>). Saponins, a novel type of plant-derived secondary metabolites, modulate gut microbiota composition and exhibit anti-metastasis activities in multiple tumors, including lung adenocarcinoma, alcohol-induced liver disease, and colorectal cancer (<xref ref-type="bibr" rid="B37">Khan et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B5">Chen et&#xa0;al., 2020a</xref>; <xref ref-type="bibr" rid="B91">Zhou et&#xa0;al., 2021</xref>). Ginsenoside Rh2 (G-Rh2), a major bioactive ingredient in ginseng, suggested the therapeutic effects of G-Rh2 on lung cancer. G-Rh2 regulated the phenotype of macrophages and affected the migration of non-small cell lung cancer (NSCLC) cells (<xref ref-type="bibr" rid="B42">Li et&#xa0;al., 2018</xref>). On the other hand, the gastrointestinal microbiome plays an important role in drug metabolism. Ginsenoside is difficult for the molecules to directly exert the pharmacological effects, and the gut flora and its metabolites can improve this process (<xref ref-type="bibr" rid="B79">Yang et&#xa0;al., 2020</xref>). A triterpenoid saponin glycoside found in licorice roots is called glycyrrhizic acid (GA). Wu et&#xa0;al. discovered that glycyrrhizin prevented PDX mice from developing lung tumors (<xref ref-type="bibr" rid="B76">Wu et&#xa0;al., 2018</xref>). And high amount of High Mobility Group Box 1 (HMGB1) facilitated lung cancer cell invasion and migration, which glycyrrhizin reduced. Here, Qiu et&#xa0;al. found that GA regulates GM to inhibit the establishment of pre-metastatic niches and metastasis that are promoted by HFD by reducing M1-like colonic macrophages <italic>via</italic> LPS/HMGB1/NF-&#x3ba;B signaling. The regulation of intestinal flora is mainly reflected in decreasing the <italic>Clostridiales</italic> order and <italic>Desulfovibrio</italic> genus, and reducing the ratio between <italic>Firmicutes</italic> and <italic>Bacteroidetes</italic> (<xref ref-type="bibr" rid="B56">Qiu et&#xa0;al., 2019</xref>). A polysaccharide obtained from Spirulina (PSP) decreased the tumor volume and weight of the lung cancer-bearing mice through regulated arachidonic acid metabolism and the balance of gut microbiota. And the PSP increased the abundance of <italic>Lactobacillus</italic>, <italic>Allobaculum</italic>, <italic>Alloprevotella</italic>, and <italic>Olsenella</italic> and decreased <italic>Bacteroides</italic> and <italic>Acinetobacter</italic> (<xref ref-type="bibr" rid="B47">Lu et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>Compound formulation of TCM</title>
<p>Bovis calculus (Bos taurus domesticus Gmelin), Olibanum (Boswcllia bhaurdajiana Birdw., Boszvellia carterii Birdw.), Myrrha, and Moschus are the four herbs that make up the Xihuang pill (XHW), a Chinese medicine formula that has been approved (state medical permit number Z11020073) (Commiphora molmol Engl., Commiphora myrrha Engl.) (<xref ref-type="bibr" rid="B85">Zhang et&#xa0;al., 2021b</xref>). It has been widely used in the treatment of a variety of malignant tumors in clinics in China, including breast cancer, lung cancer, gastric cancer, and other malignant tumors (<xref ref-type="bibr" rid="B70">Wang et&#xa0;al., 2020a</xref>; <xref ref-type="bibr" rid="B71">Wang et&#xa0;al., 2021a</xref>; <xref ref-type="bibr" rid="B18">Ge et&#xa0;al., 2022</xref>). In mice with Lewis lung cancer, Cao et&#xa0;al. investigated the anti-lung cancer impact of XHW coupled with anlotinib (LLC). They clarified the regulatory features of XHW in enhancing anlotinib&#x2019;s anti-lung cancer impact using GM and transcriptomics. The outcomes demonstrated that LLC-bearing mice receiving a combination therapy of XHW and anlotinib effectively suppressed tumor growth. Additionally, XHW&#x2019;s impact on the control of gut microbiota was significant, as revealed by 16s rRNA sequencing research. The percentage of the helpful bacteria <italic>Bacteroides</italic> and <italic>g_norank_f_ Muribaculaceae</italic> increased as a result (<xref ref-type="bibr" rid="B4">Cao et&#xa0;al., 2022</xref>). BuFeiXiaoJiYin (BFXJY) is a traditional Chinese medicine (TCM) compound that has been shown to have good effects in the treatment of lung cancer by ameliorating the NLRP3 inflammation response and regulating gut microbiota. Jiang et&#xa0;al. found that BFXJY reduced the relative abundance of <italic>Firmicutes</italic> and <italic>Verrucomicrobia</italic>, increased the relative abundance of <italic>Bacteroidetes</italic> and <italic>Epsilonbacteraeota</italic>, and enhanced the relative abundance of <italic>Deferribacteres</italic> (<xref ref-type="bibr" rid="B33">Jiang et&#xa0;al., 2022</xref>). A Chinese clinical study suggests that Huayu Kangai decoction enema is effective in the treatment of lung cancer and can improve the level of lactic acid bacteria and bifidobacteria (<xref ref-type="bibr" rid="B32">Jia et&#xa0;al., 2023</xref>).</p>
<p>In sum, many of the herbal medicines could modulate the relationship between the host and the gut microbiota (GM) to exert their beneficial properties on the host. However, most current studies are mainly one-way studies, which mainly observe the changes in flora and metabolites after the treatment of diseases with traditional Chinese medicine. There will be some problems in this process. For example, Chinese herbs themselves will affect intestinal flora, and intestinal flora is needed for the metabolism and absorption of Chinese herbs. Changes in flora caused by these life processes may not play a major role in the treatment of diseases. In addition, the metabolic components of traditional Chinese medicine are diverse, and some metabolites may be repeated with those of the bacterial community. Therefore, there are many problems in the study of the treatment of lung cancer by regulating intestinal flora with traditional Chinese medicine, and researchers could try their best to improve the experimental scheme and reduce the above problems.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>There are objective differences between lung cancer patients and healthy people in intestinal flora, and more and more studies are gradually proving that by regulating intestinal flora, increasing probiotics, and reducing harmful bacteria content, the cancer inhibitory signaling pathway can be more activated, anti-tumor immunity can be enhanced, thus inducing apoptosis of cancer cells or preventing recurrence and metastasis, and it can play a synergistic role with tumor therapeutic drugs. This paper summarizes and analyzes the regulation of intestinal flora by active ingredients of TCM and Chinese herbal compounds and their intervention effects. Various microbial-related therapeutic means represented by fecal bacteria transplantation and Chinese medicine intervention have been widely used in the fields of diabetes, kidney disease, liver disease, inflammatory bowel disease, and are expected to be popularized in the treatment of cancer, psychiatric diseases, cardiovascular diseases, and so on. Which is conducive to providing new strategies and ideas for clinical prevention and treatment of NSCLC. At present, studies show that TCM regulates intestinal flora to repair the intestinal mucosal barrier and treats NSCLC mainly in two aspects: by affecting immune cells to restore normal immune function of the intestinal mucosa and by improving the sensitivity of antitumor drugs by regulating intestinal flora itself or metabolites. On the other hand, some TCM ingredients cannot be directly absorbed into the blood to play a role in the treatment of diseases, and intestinal flora can achieve drug transformation in this process. With the advantages of multi-target, all-directional, multi-component, and light side effects, TCM intervention in NSCLC has been recognized as a broad prospect. However, the composition of traditional Chinese medicine is complex, and its mechanism of action has not been fully elucidated. In addition, there are a few studies on the treatment of NSCLC through the regulation of intestinal flora by traditional Chinese medicine. Therefore, a large number of basic and clinical studies are needed in the TCM treatment of NSCLC.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>XW and LH collected the articles, MC and JL made the figures. JX guided XW and LH in collecting articles and making figures. MW prerevised the manuscript. XW and LH wrote the manuscript and made the tables. XW and LH have the same contribution to the article. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Natural Science Foundation of China (NSFC:21272214).</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adak</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>M. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An insight into gut microbiota and its functionalities</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>76</volume>, <fpage>473</fpage>&#x2013;<lpage>493</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-018-2943-4</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berding</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Vlckova</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Marx</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Schellekens</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Stanton</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Diet and the microbiota&#x2013;Gut&#x2013;Brain axis: Sowing the seeds of good mental health</article-title>. <source>Adv. Nutr.</source> <volume>12</volume>, <fpage>1239</fpage>&#x2013;<lpage>1285</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/advances/nmaa181</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botticelli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vernocchi</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Marini</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Quagliariello</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Cerbelli</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Reddel</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment</article-title>. <source>J. Transl. Med.</source> <volume>18</volume>, <fpage>49</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12967-020-02231-0</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Xihuang pill enhances anticancer effect of anlotinib by regulating gut microbiota composition and tumor angiogenesis pathway</article-title>. <source>Biomed Pharmacother</source> <volume>151</volume>, <elocation-id>113081</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2022.113081</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>M.-Y.</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Rao</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H.-H.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>a). <article-title>Panax notoginseng saponins prevent colitis-associated colorectal cancer development: the role of gut microbiota</article-title>. <source>Chin. J. Natural Medicines</source> <volume>18</volume>, <fpage>500</fpage>&#x2013;<lpage>507</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1875-5364(20)30060-1</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>b). <article-title>Sodium butyrate combined with docetaxel for the treatment of lung adenocarcinoma A549 cells by targeting Gli1</article-title>. <source>OTT Volume</source> <volume>13</volume>, <fpage>8861</fpage>&#x2013;<lpage>8875</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/OTT.S252323</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>a). <article-title>Ginsenoside Rg1 mitigates morphine dependence <italic>via</italic> regulation of gut microbiota, tryptophan metabolism, and serotonergic system function</article-title>. <source>Biomed Pharmacother</source> <volume>150</volume>, <elocation-id>112935</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2022.112935</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Qian</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>c). <article-title>
<italic>Akkermansia muciniphila</italic> enhances the antitumor effect of cisplatin in Lewis lung cancer mice</article-title>. <source>J. Immunol. Res.</source> <volume>2020</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2020/2969287</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>b). <article-title>FuZhengHuaYuJiangZhuTongLuoFang prescription modulates gut microbiota and gut-derived metabolites in UUO rats</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.837205</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>b). <article-title>Role and mechanism of gut microbiota in human disease</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.625913</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ke</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>a). <article-title>Propionate and butyrate produced by gut microbiota after probiotic supplementation attenuate lung metastasis of melanoma cells in mice</article-title>. <source>Mol. Nutr. Food Res.</source> <volume>65</volume>, <elocation-id>2100096</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mnfr.202100096</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corr&#xea;a</surname> <given-names>R. O.</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>P. R.</given-names>
</name>
<name>
<surname>Moser</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Quesniaux</surname> <given-names>V. F. J.</given-names>
</name>
<name>
<surname>Vinolo</surname> <given-names>M. A. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Butyrate: Connecting the gut-lung axis to the management of pulmonary disorders</article-title>. <source>Front. Nutr.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnut.2022.1011732</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cristiano</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cuozzo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Coretti</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Liguori</surname> <given-names>F. M.</given-names>
</name>
<name>
<surname>Cimmino</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Turco</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction</article-title>. <source>Biomed Pharmacother</source> <volume>153</volume>, <elocation-id>113528</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2022.113528</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Goh</surname> <given-names>W.-R.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Yue</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Khine</surname> <given-names>W. W. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Revisit gut microbiota and its impact on human health and disease</article-title>. <source>J. Food Drug Anal.</source> <volume>27</volume>, <fpage>623</fpage>&#x2013;<lpage>631</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jfda.2018.12.012</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname> <given-names>W.-W.</given-names>
</name>
<name>
<surname>Xuan</surname> <given-names>F.-L.</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>F.-L.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Comparative analysis of the rats&#x2019; gut microbiota composition in animals with different ginsenosides metabolizing activity</article-title>. <source>J. Agric. Food Chem.</source> <volume>65</volume>, <fpage>327</fpage>&#x2013;<lpage>337</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.jafc.6b04848</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Pedersen</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Gut microbiota in human metabolic health and disease</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>19</volume>, <fpage>55</fpage>&#x2013;<lpage>71</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-020-0433-9</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fulde</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hornef</surname> <given-names>M. W.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Maturation of the enteric mucosal innate immune system during the postnatal period</article-title>. <source>Immunol. Rev.</source> <volume>260</volume>, <fpage>21</fpage>&#x2013;<lpage>34</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12190</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ge</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The efficacy and safety of xihuang pill/capsule in adjuvant treatment of breast cancer: A systematic review and meta-analysis of 26 randomized controlled trials</article-title>. <source>J. Ethnopharmacol</source> <volume>295</volume>, <elocation-id>115357</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2022.115357</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Georgiou</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Marinov</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Farooqi</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Gazouli</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Gut microbiota in lung cancer: Where do we stand</article-title>? <source>IJMS</source> <volume>22</volume>, <elocation-id>10429</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms221910429</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Hypoglycemic effect of astragaloside IV <italic>via</italic> modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/AKT pathway</article-title>. <source>J. Ethnopharmacol</source> <volume>281</volume>, <elocation-id>114558</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2021.114558</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grenda</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Iwan</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Chmielewska</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Krawczyk</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Giza</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bomba</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Presence of akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer</article-title>. <source>AMB Expr</source> <volume>12</volume>, <elocation-id>86</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13568-022-01428-4</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xfc;&#xe7;l&#xfc;-&#xdc;st&#xfc;nda&#x11f;</surname> <given-names>&#xd6;.</given-names>
</name>
<name>
<surname>Mazza</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Saponins: Properties, applications and processing</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source> <volume>47</volume>, <fpage>231</fpage>&#x2013;<lpage>258</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408390600698197</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Sang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>a). <article-title>Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon</article-title>. <source>Carbohydr. Polymers</source> <volume>267</volume>, <elocation-id>118231</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.carbpol.2021.118231</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>b). <article-title>Ginsenoside Rg1 improves cognitive capability and affects the microbiota of large intestine of tree shrew model for alzheimer&#x2019;s disease</article-title>. <source>Mol. Med. Rep.</source> <volume>23</volume>, <fpage>291</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2021.11931</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hakozaki</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Nolin-Lapalme</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kogawa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Okuma</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Moreau-Amaru</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Cancer cachexia among patients with advanced non-Small-Cell lung cancer on immunotherapy: An observational study with exploratory gut microbiota analysis</article-title>. <source>Cancers</source> <volume>14</volume>, <elocation-id>5405</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers14215405</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hakozaki</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Richard</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Elkrief</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hosomi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Benla&#xef;faoui</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mimpen</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The gut microbiome associates with immune checkpoint inhibition outcomes in patients with advanced non&#x2013;small cell lung cancer</article-title>. <source>Cancer Immunol. Res.</source> <volume>8</volume>, <fpage>1243</fpage>&#x2013;<lpage>1250</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/2326-6066.CIR-20-0196</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Astragalus membranaceus and salvia miltiorrhiza ameliorates cyclosporin a-induced chronic nephrotoxicity through the &#x201c;gut-kidney axis&#x201d;</article-title>. <source>J. Ethnopharmacol</source> <volume>269</volume>, <elocation-id>113768</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2020.113768</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heintz-Buschart</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Wilmes</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Human gut microbiome: Function matters</article-title>. <source>Trends Microbiol.</source> <volume>26</volume>, <fpage>563</fpage>&#x2013;<lpage>574</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tim.2017.11.002</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hooper</surname> <given-names>L. V.</given-names>
</name>
<name>
<surname>Littman</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Macpherson</surname> <given-names>A. J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Interactions between the microbiota and the immune system</article-title>. <source>Science</source> <volume>336</volume>, <fpage>1268</fpage>&#x2013;<lpage>1273</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1223490</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy</article-title>. <source>Gut</source> <volume>71</volume>, <fpage>734</fpage>&#x2013;<lpage>745</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2020-321031</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hufnagl</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Pali-Sch&#xf6;ll</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Roth-Walter</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Jensen-Jarolim</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Dysbiosis of the gut and lung microbiome has a role in asthma</article-title>. <source>Semin. Immunopathol.</source> <volume>42</volume>, <fpage>75</fpage>&#x2013;<lpage>93</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00281-019-00775-y</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Effect of huayu anticancer decoction enema combined with auricular point pressing on intestinal flora and inflammatory factors in lung cancer patients</article-title>. <source>Minerva Surg.</source> <volume>78</volume>, <page-range>123&#x2013;125</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.23736/S2724-5691.21.09339-4</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Man</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>BuFeiXiaoJiYin ameliorates the NLRP3 inflammation response and gut microbiota in mice with lung cancer companied with qi-yin deficiency</article-title>. <source>Cancer Cell Int.</source> <volume>22</volume>, <fpage>121</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12935-022-02543-9</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>The diversity of gut microbiome is associated with favorable responses to anti&#x2013;programmed death 1 immunotherapy in Chinese patients with NSCLC</article-title>. <source>J. Thorac. Oncol.</source> <volume>14</volume>, <fpage>1378</fpage>&#x2013;<lpage>1389</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jtho.2019.04.007</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jing</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Absorption of <italic>Codonopsis pilosula</italic> saponins by coexisting polysaccharides alleviates gut microbial dysbiosis with dextran sulfate sodium-induced colitis in model mice</article-title>. <source>BioMed. Res. Int.</source> <volume>2018</volume>, <fpage>1</fpage>&#x2013;<lpage>18</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2018/1781036</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamada</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>G. Y.</given-names>
</name>
<name>
<surname>Inohara</surname> <given-names>N.</given-names>
</name>
<name>
<surname>N&#xfa;&#xf1;ez</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Control of pathogens and pathobionts by the gut microbiota</article-title>. <source>Nat. Immunol.</source> <volume>14</volume>, <fpage>685</fpage>&#x2013;<lpage>690</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2608</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Leong</surname> <given-names>W. K.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Mushroom polysaccharides and jiaogulan saponins exert cancer preventive effects by shaping the gut microbiota and microenvironment in apc mice</article-title>. <source>Pharmacol. Res.</source> <volume>148</volume>, <elocation-id>104448</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2019.104448</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Ryu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Min</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer</article-title>. <source>Mol. Med. Rep</source>. <volume>20</volume>, <fpage>1569</fpage>&#x2013;<lpage>1574</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2019.10431</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sasaki</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Fukutani</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ohsawa</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Yohda</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Anticancer saponin OSW-1 is a novel class of selective golgi stress inducer</article-title>. <source>Bioorganic Medicinal Chem. Lett.</source> <volume>29</volume>, <fpage>1732</fpage>&#x2013;<lpage>1736</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bmcl.2019.05.022</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knezevic</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Starchl</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Tmava Berisha</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Amrein</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Thyroid-Gut-Axis: How does the microbiota influence thyroid function</article-title>? <source>Nutrients</source> <volume>12</volume>, <elocation-id>1769</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12061769</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leigh</surname> <given-names>S.-J.</given-names>
</name>
<name>
<surname>Morris</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Diet, inflammation and the gut microbiome: Mechanisms for obesity-associated cognitive impairment</article-title>. <source>Biochim. Biophys. Acta (BBA) - Mol. Basis Dis.</source> <volume>1866</volume>, <elocation-id>165767</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2020.165767</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Teng</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2</article-title>. <source>BMC Cancer</source> <volume>18</volume>, <fpage>579</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12885-018-4299-4</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A flavonoid-rich <italic>Smilax china</italic> l. extract prevents obesity by upregulating the adiponectin-receptor/AMPK signalling pathway and modulating the gut microbiota in mice</article-title>. <source>Food Funct.</source> <volume>12</volume>, <fpage>5862</fpage>&#x2013;<lpage>5875</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/D1FO00282A</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lianqun</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yixin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Si</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Xiaoming</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Nan</surname> <given-names>S.</given-names>
</name>
<etal/>
<etal/>
</person-group> (<year>2021</year>). <article-title>Comprehensive multiomics analysis of the effect of ginsenoside Rb1 on hyperlipidemia</article-title>. <source>Aging</source> <volume>13</volume>, <fpage>9732</fpage>&#x2013;<lpage>9747</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/aging.202728</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.-Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>M.-J.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Z.-M.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Y.-Q.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>T.-Q.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Baicalin attenuate diet-induced metabolic syndrome by improving abnormal metabolism and gut microbiota</article-title>. <source>Eur. J. Pharmacol.</source> <volume>925</volume>, <elocation-id>174996</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2022.174996</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Jian</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>
<italic>Astragalus</italic> polysaccharide alleviates constipation in the elderly <italic>Via</italic> modification of gut microbiota and fecal metabolism</article-title>. <source>Rejuvenation Res.</source> <volume>25</volume>, <fpage>275</fpage>&#x2013;<lpage>290</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/rej.2022.0039</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Spirulina polysaccharide induces the metabolic shifts and gut microbiota change of lung cancer in mice</article-title>. <source>Curr. Res. Food Sci.</source> <volume>5</volume>, <fpage>1313</fpage>&#x2013;<lpage>1319</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.crfs.2022.08.010</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Gut microbiota combined with metabolomics reveals the metabolic profile of the normal aging process and the anti-aging effect of FuFang zhenshu TiaoZhi(FTZ) in mice</article-title>. <source>Biomed Pharmacother</source> <volume>121</volume>, <elocation-id>109550</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2019.109550</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Xiang</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A monomeric polysaccharide from polygonatum sibiricum improves cognitive functions in a model of alzheimer&#x2019;s disease by reshaping the gut microbiota</article-title>. <source>Int. J. Biol. Macromolecules</source> <volume>213</volume>, <fpage>404</fpage>&#x2013;<lpage>415</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.05.185</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirzaei</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Afaghi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Babakhani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sohrabi</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Hosseini-Fard</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Babolhavaeji</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Role of microbiota-derived short-chain fatty acids in cancer development and prevention</article-title>. <source>Biomed Pharmacother</source> <volume>139</volume>, <elocation-id>111619</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2021.111619</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagasaka</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sexton</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Alhasan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Rahman</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Azmi</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Sukari</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer&#x2013;a review</article-title>. <source>Crit. Rev. Oncol/Hematol</source> <volume>145</volume>, <elocation-id>102841</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.critrevonc.2019.102841</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nie</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>The experimental exploration of TCM theory &#x201c;Treating the same disease with different approaches&#x201d; on an ulcerative colitis model</article-title>. <source>Evidence-Based Complementary Altern. Med.</source> <volume>2022</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/4916540</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname> <given-names>T. T.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>A. Q.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Effect of yangyin qingfei decoction on skin damage and intestinal flora in patients with lung cancer after radiotherapy</article-title>. <source>Liaoning J. Traditional Chin. Med.</source> <volume>01</volume>, <fpage>97</fpage>&#x2013;<lpage>100</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.13192/j.iSSN.1000-1719.2023.01.028</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The gut microbiome is associated with clinical response to anti&#x2013;PD-1/PD-L1 immunotherapy in gastrointestinal cancer</article-title>. <source>Cancer Immunol. Res.</source> <volume>8</volume>, <fpage>1251</fpage>&#x2013;<lpage>1261</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/2326-6066.CIR-19-1014</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Maroccia</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Hammarberg Ferri</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Fiorentini</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Role of the microbiota in lung cancer: Insights on prevention and treatment</article-title>. <source>IJMS</source> <volume>23</volume>, <elocation-id>6138</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23116138</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Modulation of intestinal microbiota by glycyrrhizic acid prevents high-fat diet-enhanced pre-metastatic niche formation and metastasis</article-title>. <source>Mucosal Immunol.</source> <volume>12</volume>, <fpage>945</fpage>&#x2013;<lpage>957</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-019-0144-6</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Routy</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Le Chatelier</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Derosa</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Duong</surname> <given-names>C. P. M.</given-names>
</name>
<name>
<surname>Alou</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Daill&#xe8;re</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Gut microbiome influences efficacy of PD-1&#x2013;based immunotherapy against epithelial tumors</article-title>. <source>Science</source> <volume>359</volume>, <fpage>91</fpage>&#x2013;<lpage>97</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aan3706</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rutsch</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kantsj&#xf6;</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Ronchi</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The gut-brain axis: How microbiota and host inflammasome influence brain physiology and pathology</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.604179</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>S&#xe1;nchez-Alcoholado</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Ord&#xf3;&#xf1;ez</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Otero</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Plaza-Andrade</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Laborda-Illanes</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Medina</surname> <given-names>J. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer</article-title>. <source>IJMS</source> <volume>21</volume>, <elocation-id>6782</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21186782</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shan</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Berberine attenuates hyperuricemia by regulating urate transporters and gut microbiota</article-title>. <source>Am. J. Chin. Med.</source> <volume>50</volume>, <fpage>2199</fpage>&#x2013;<lpage>2221</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1142/S0192415X22500951</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Tyagi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bhansali</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Pareek</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Ilyas</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Saponins: Extraction, bio-medicinal properties and way forward to anti-viral representatives</article-title>. <source>Food Chem. Toxicol.</source> <volume>150</volume>, <elocation-id>112075</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2021.112075</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Sinomenine ameliorates septic acute lung injury in mice by modulating gut homeostasis <italic>via</italic> aryl hydrocarbon receptor/Nrf2 pathway</article-title>. <source>Eur. J. Pharmacol.</source> <volume>912</volume>, <elocation-id>174581</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2021.174581</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>S.-S.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H.-W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An insoluble polysaccharide from the sclerotium of poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice <italic>via</italic> modulation of gut microbiota</article-title>. <source>Chin. J. Natural Medicines</source> <volume>17</volume>, <fpage>3</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1875-5364(19)30003-2</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takada</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Shimokawa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Takamori</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shimamatsu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hirai</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Tagawa</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Clinical impact of probiotics on the efficacy of <sc>anti-PD</sc> -1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting</article-title>. <source>Intl J. Cancer</source> <volume>149</volume>, <fpage>473</fpage>&#x2013;<lpage>482</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.33557</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>W. H. W.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D. Y.</given-names>
</name>
<name>
<surname>Hazen</surname> <given-names>S. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Dietary metabolism, the gut microbiome, and heart failure</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>16</volume>, <fpage>137</fpage>&#x2013;<lpage>154</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41569-018-0108-7</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>A comprehensive analysis of microflora and metabolites in the development of ulcerative colitis into colorectal cancer based on the lung&#x2013;gut correlation theory</article-title>. <source>Molecules</source> <volume>27</volume>, <elocation-id>5838</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27185838</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vernocchi</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Gili</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Conte</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Del Chierico</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Conta</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Miccheli</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Network analysis of gut microbiome and metabolome to discover microbiota-linked biomarkers in patients affected by non-small cell lung cancer</article-title>. <source>IJMS</source> <volume>21</volume>, <elocation-id>8730</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21228730</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Vlamakis</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J. W. J.</given-names>
</name>
<name>
<surname>Besse</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Xanthakis</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Vasan</surname> <given-names>R. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease</article-title>. <source>Genome Med.</source> <volume>13</volume>, <fpage>188</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13073-021-01007-5</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>b). <article-title>Baicalein ameliorates ionizing radiation-induced injuries by rebalancing gut microbiota and inhibiting apoptosis</article-title>. <source>Life Sci.</source> <volume>261</volume>, <elocation-id>118463</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2020.118463</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>a). <article-title>Efficacy and safety of xihuang pill for lung cancer: A protocol for systematic review and meta-analysis</article-title>. <source>Medicine</source> <volume>99</volume>, <elocation-id>e22516</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MD.0000000000022516</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>a). <article-title>Efficacy and safety of xihuang pill for gastric cancer: A protocol for systematic review and meta-analysis</article-title>. <source>Medicine</source> <volume>100</volume>, <elocation-id>e25726</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MD.0000000000025726</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>b). <article-title>Xuanbai chengqi decoction ameliorates pulmonary inflammation <italic>via</italic> reshaping gut microbiota and rectifying Th17/Treg imbalance in a murine model of chronic obstructive pulmonary disease</article-title>. <source>COPD Volume</source> <volume>16</volume>, <fpage>3317</fpage>&#x2013;<lpage>3335</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/COPD.S337181</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Doherty</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>a). <article-title>Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies</article-title>. <source>eBioMedicine</source> <volume>80</volume>, <elocation-id>104055</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104055</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>b). <article-title>
<italic>Acanthopanax senticosus</italic> total flavonoids alleviate lipopolysaccharide-induced intestinal inflammation and modulate the gut microbiota in mice</article-title>. <source>Bioscience Rep.</source> <volume>42</volume>, <elocation-id>BSR20212670</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BSR20212670</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weersma</surname> <given-names>R. K.</given-names>
</name>
<name>
<surname>Zhernakova</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Interaction between drugs and the gut microbiome</article-title>. <source>Gut</source> <volume>69</volume>, <fpage>1510</fpage>&#x2013;<lpage>1519</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2019-320204</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Glycyrrhizin suppresses the growth of human NSCLC cell line HCC827 by downregulating HMGB1 level</article-title>. <source>BioMed. Res. Int.</source> <volume>2018</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2018/6916797</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Sodium butyrate-activated TRAF6-TXNIP pathway affects A549 cells proliferation and migration</article-title>. <source>Cancer Med.</source> <volume>9</volume>, <fpage>3477</fpage>&#x2013;<lpage>3488</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cam4.2564</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Gut microbiota-dependent catabolites of tryptophan play a predominant role in the protective effects of turmeric polysaccharides against DSS-induced ulcerative colitis</article-title>. <source>Food Funct.</source> <volume>12</volume>, <fpage>9793</fpage>&#x2013;<lpage>9807</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/D1FO01468D</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities</article-title>. <source>Drug Metab. Rev.</source> <volume>52</volume>, <fpage>125</fpage>&#x2013;<lpage>138</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/03602532.2020.1714645</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ying</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Cultured cordyceps sinensis polysaccharides modulate intestinal mucosal immunity and gut microbiota in cyclophosphamide-treated mice</article-title>. <source>Carbohydr. Polymers</source> <volume>235</volume>, <elocation-id>115957</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.carbpol.2020.115957</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hrusch</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Fei</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Barr&#xf3;n</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Mills</surname> <given-names>K. A. M.</given-names>
</name>
<name>
<surname>Hollinger</surname> <given-names>M. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Gut microbiota modulates bleomycin-induced acute lung injury response in mice</article-title>. <source>Respir. Res.</source> <volume>23</volume>, <fpage>337</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12931-022-02264-7</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review</article-title>. <source>Carbohydr. Polymers</source> <volume>183</volume>, <fpage>91</fpage>&#x2013;<lpage>101</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.carbpol.2017.12.009</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>W.-J.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.-L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Changes in intestinal microbiota affect metabolism of ginsenoside re</article-title>. <source>Biomed. Chromatogr.</source> <volume>32</volume>, <elocation-id>e4284</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/bmc.4284</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>a). <article-title>Beneficial effect of alkaloids from sophora alopecuroides l. @ on CUMS-induced depression model mice <italic>via</italic> modulating gut microbiota</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.665159</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y.-Z.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J.-Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>R.-X.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.-C.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>b). <article-title>Network pharmacology&#x2013;based identification of key mechanisms of xihuang pill in the treatment of triple-negative breast cancer stem cells</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2021.714628</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>S.-S.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>N.-N.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S.-J.</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>Y.-F.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Glycosides and flavonoids from the extract of <italic>Pueraria thomsonii</italic> benth leaf alleviate type 2 diabetes in high-fat diet plus streptozotocin-induced mice by modulating the gut microbiota</article-title>. <source>Food Funct.</source> <volume>13</volume>, <fpage>3931</fpage>&#x2013;<lpage>3945</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/D1FO04170C</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>F.</given-names>
</name>
<name>
<surname>An</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Shan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Specific gut microbiome and serum metabolome changes in lung cancer patients</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.725284</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition</article-title>. <source>J. Cell. Mol. Medi</source> <volume>26</volume>, <fpage>1060</fpage>&#x2013;<lpage>1070</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcmm.17158</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Rong</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats</article-title>. <source>Food Funct.</source> <volume>13</volume>, <fpage>7287</fpage>&#x2013;<lpage>7301</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/D2FO01009G</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Kou</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Akebia saponin d regulates the metabolome and intestinal microbiota in high fat diet-induced hyperlipidemic rats</article-title>. <source>Molecules</source> <volume>24</volume>, <elocation-id>1268</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules24071268</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Astragalus polysaccharides and saponins alleviate liver injury and regulate gut microbiota in alcohol liver disease mice</article-title>. <source>Foods</source> <volume>10</volume>, <elocation-id>2688</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/foods10112688</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>